Laboratory services

CodeServicePrice, euroPrice, roub
CLINICAL DIAGNOSTIC LABORATORY
BLOOD ANALYSIS
A000 Cell Blood Count+differential 47 3 380
A002 Cell Blood Count 27 1 942
A005 Sedimentation rate 16 1 151
A008 Reticulocytes 13 935
A009 Matching of blood and compatibility test 265 19 060
A010 Time of coagulation 13 935
A015 Time of bleeding 13 935
M125 Malaria test 67 4 819
URINE ANALYSIS
B500 Standard urine test 13 935
B502 Standard urine test with microscopy 24 1 726
B510 Urine pregnancy test (screening) 13 935
B511 Nechiporenko urine test 20 1 438
B512 Zimnitsky urine test 53 3 812
B513 3-portions urine test examination 40 2 877
B514 2-portions urine test examination 27 1 942
B515 Urine precipitate - Microscopy 13 935
B517 Creatinine Clearance 53 3 812
STOOL ANALYSIS
B306 Fecal examination for pancreatic elastase-1 50 3 596
M105 Coprology total 27 1 942
M110 Coprology (occult blood) 13 935
M111 Carbohydrates in faeces 40 2 877
M115 Enterobiasis 20 1 438
M120 Eggs of helminths (+protozoa) 27 1 942
M122 Protozoa in faeces 20 1 438
M390 Adenovirus and rotavirus (in stool) 28 2 014
M392 Cryptosporidium, Giardia, Entamoeba histolytica in stool 41 2 949
M391 Helicobacter pylori(in stool) 27 1 942
M393 Verotoxin in stool 50 3 596
M394 Norovirus in stool 25 1 798
M395 Calprotectin in stool (quantitative) 50 3 596
M396 Clostridium Difficile Toxin A & B 65 4 675
SPUTUM ANALYSIS
M150 Standard sputum test 27 1 942
M002 Nasal slime general clinical research 27 1 942
M355 M. Tuberculosis in sputum 33 2 373
SKIN& NAIL PLATES
M155 Examination of skin plate or nail plate for pathogenic fungi (one test) 47 3 380
M210 Demodex folliculorum 20 1 438
BIOCHEMICAL HAIR ANALYSIS
B208 Heavy metals and trace elements (23 elements) complex hair test Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb 150 10 788
TESTS OF THE UROGENITAL SYSTEMS
M220 Standard Vaginal Smear Test 20 1 438
M221 Standard Cervical Smear Test 20 1 438
M222 Standard Urethral Smear Test 20 1 438
M223 Standard prostatic fluid test 27 1 942
SEROUS CAVITIES& CYSTS FLUID TESTS
B620 Standard Synovial Fluid Test 27 1 942
B621 Standard Serous Fluid test 27 1 942
CEREBROSPINAL FLUID TESTS
B622 Standard cerebrospinal fluid test 33 2 373
B623 Glucose in cerebrospinal fluid 17 1 223
B624 Protein in cerebrospinal fluid 17 1 223
HEMOSTASIS SYSTEM
A020 APTT 16 1 151
A025 Prothrombin+INR 27 1 942
A027 Thrombin time 22 1 582
A030 Fibrinogen 16 1 151
A035 Antithrombin III 27 1 942
C139 Protein-C 47 3 380
C142 Protein-S 47 3 380
C515 D-DIMER 60 4 315
C305 Lupus anticoagulant (panel) 53 3 812
A033 Platelet Aggregation 83 5 970
A031 FACTOR VON 170 12 227
A068 Fractions of hemoglobin (carboxyhemoglobin and methemoglobin) 30 2 158
BLOOD DRUG RATES
B142 Folic acid 27 1 942
C710 Determination of ethanol in the blood 60 4 315
T010 Digoxin 78 5 610
T015 Determination of phenobarbital in blood 53 3 812
T020 Phenytoin 53 3 812
T025 Valproic Acid 53 3 812
T030 Carbamazepine 53 3 812
T080 Determination of tacrolimus in blood 55 3 956
T085 Levetiracetam (Keppra) 100 7 192
T097 Therapeutic drug monitoring of Topiramate 22 1 582
T098 Therapeutic drug monitoring of oxcarbazepine by its active metabolite (single sample analysis) 22 1 582
T100 Determination of the concentration of Amikacin in the blood 40 2 877
T101 The determination of the concentration of Gentamicin in the blood 40 2 877
T102 Determine the concentration of Vancomycin in the blood 40 2 877
NARCOTIC SCREENING
T035 Methamphetamine 33 2 373
T040 Cannabis 33 2 373
T045 Cocaine 33 2 373
T050 Opiates / QUICK TEST 33 2 373
T060 Сotinine 33 2 373
T070 Benzodiazepines 53 3 812
T075 Drug screening in urine 53 3 812
T086 Determination of the fraction transferin (CDT) (diagnosis of alcohol abuse) 39 2 805
T087 Hair analysis for determination of drug means, psychotropic or potent substances. (method GC – MS, HPLC) 187 13 450
T096 Urinalysis "bad habits" (nicotine, a psychotropic and narcotic substance, a psychoactive drug substances) 53 3 812
BLOOD BIOCHEMISTRY
A060 Vitamin B12 27 1 942
B002 Iron saturation of transferrin + Transferrin + Iron 39 2 805
B003 Ceruloplasmin 50 3 596
B004 Eosinophil Cationic Protein (ECP) 50 3 596
B007 Cuprum 22 1 582
B100 Glucose 13 935
B101 Standard glucose tolerance test 33 2 373
B102 Vitamin D 107 7 696
B103 Vitamin A 83 5 970
B104 Vitamin B1 83 5 970
B105 Cholesterol 13 935
B107 Pregnancy glucose tolerance test 33 2 373
B108 Vitamin B5 83 5 970
B109 Vitamin B6 83 5 970
B110 Cholesterol-HDL 20 1 438
B112 Vitamin C 83 5 970
B113 Vitamin E 83 5 970
B114 Vitamin K 83 5 970
B115 Cholesterol-LDL 20 1 438
B118 Lactate 25 1 798
B120 Triglycerides 13 935
B122 Angiotensin converting enzyme (ACE) 45 3 237
B125 Bilirubin total 13 935
B130 Bilirubin direct 13 935
B135 Albumin 13 935
B137 Homocysteine 67 4 819
B140 Creatinine 13 935
B144 Zink 38 2 733
B145 Iron 16 1 151
B148 Litium 74 5 322
B150 Iron binding capacity 20 1 438
B155 Total protein 13 935
B160 Protein fractionation (Electrophoresis) 27 1 942
B165 Lipoprotein A 27 1 942
B166 APO-A-1 protein 27 1 942
B167 APO-B protein 27 1 942
B170 Urea 13 935
B175 Uric acid 13 935
B180 Fructosamine 20 1 438
B187 Determination of prealbumin in blood serum 89 6 401
B188 Determination of bile acids in blood 45 3 237
B200 Calcium (total) 16 1 151
B202 Calcium (ionised) 20 1 438
B203 Heavy metals and trace elements (23 elements Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb) complex blood test 150 10 788
B205 Sodium/Potassium/Chloride 16 1 151
B207 Blood gases: рО2,рСО2,рН from venous blood + calculating parameters 27 1 942
B209 Blood gases: рО2,рСО2,рН from arterial blood + calculating parameters 27 1 942
B210 Magnesium 13 935
B215 Phosphate inorganic 13 935
B217 Complex blood analysis during dialysis: pH, glucose, electrolytes 136 9 782
B218 Complex blood analysis: gas and electrolyte compositions, glucose, lactate with calculated parameters in venous blood (for Maternity hospital) 47 3 380
B219 Study of dialysate for electrolyte composition, pH, glucose 131 9 422
B221 Complex blood analysis gas and electrolyte compositions, glucose, lactate in capillary blood (for Maternity hospital) 47 3 380
B300 Amylase 16 1 151
B305 Amylase pancreatic 16 1 151
B310 Lipase 16 1 151
B315 Lactatedehydrogenase (LDH) 13 935
B317 Erythropoietin 47 3 380
B320 Creatine Kinase 13 935
B325 Creatine Kinase MB 16 1 151
B330 Gamma Glutamyle Transferase (GGT) 13 935
B335 Acid phosphatase 16 1 151
B340 Alk. Phosphatase 13 935
B345 Alanine Amino Transferase (ALT) 13 935
B350 Aspartate Amino Transferase (AST) 13 935
B360 Cholinesterase 18 1 295
B400 C-Reactive Protein 20 1 438
B401 C-reactive protein high sensitivity 30 2 158
B405 Rheumatoid Factor 20 1 438
B410 Anti-streptolysin O titre 20 1 438
B411 Alfa-1-antitrypsin 27 1 942
C415 Ferritin 27 1 942
B430 Haemoglobin A1C 22 1 582
B435 Myoglobin 47 3 380
B440 Transferrin 27 1 942
B445 Troponin I 47 3 380
B450 Troponin T 47 3 380
B451 BNP (brain natriuretic peptide) 87 6 257
B556 The N-terminal peptide NT-proBNP 88 6 329
B604 Alpha-2-Macroglobuline 47 3 380
B610 Haptoglobin 47 3 380
B700 Tandem mass spectrometry (spectrum acylcarnitines, amino acids, organic acids 130 9 350
B702 Procalcitonin (quant) 60 4 315
URINE BIOCHEMISTRY
Urine Biochemistry- Random Portion
B021 Urolithiasis Early Diagnostics 47 3 380
B025 Microproteinuria 13 935
B132 Urea (random portion) 12 863
B133 Uric acid (random portion) 12 863
B139 The content of Cu (copper) in the urine (a single portion of urine) 12 863
B173 Glucose (random portion) 13 935
B182 Alpha Amylase (random portion) 18 1 295
B505 NA+/K+/Cl (random portion) 20 1 438
B204 Heavy metals and trace elements (23 elements) complex urine test Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb 150 10 788
B134 Calcium (random portion) 18 1 295
B008 The content of Cu (copper) in the urine (daily) 13 935
B703 Gas chromatography of urine (organic aciduria) 250 17 981
Biochemical Urine Analysis - 24h
B136 Albumin (24h) 18 1 295
B141 Creatinine (24h) 18 1 295
B171 Urea (24h) 18 1 295
B176 Uric acid (24h) 18 1 295
B177 Phosphate inorganic (24h) 18 1 295
B178 Magnesium (24) 18 1 295
B179 Glucose (24h) 18 1 295
B183 Total Protein (24h) 18 1 295
B506 Na (24h) 20 1 438
B507 K (24h) 20 1 438
B508 Cl (24h) 20 1 438
B516 Calcium urine test (24h) 22 1 582
B550 Oxalate in urine 40 2 877
B558 Determination of Beta-2-microglobulin (single dose of urine) 24 1 726
B562 Urine protein electrophoresis 40 2 877
B520 Stone chemistry - Profile 67 4 819
IMMUNOLOGY
Diagnostic Of The Body Immunological Status
B415 Immunoglobulin A (IgA) 19 1 367
B420 Immunoglobulin M (IgM) 19 1 367
B425 Immunoglobulin G (IgG) 19 1 367
C299 Circulating Immune Complex 22 1 582
C300 IgE total 27 1 942
C285 Interferon sensibility state 293 21 073
C288 Lymphocyte subpopulations/min.panel/(CD3,CD4,CD8,CD19,CD16(56)),CD3+HL 200 14 385
C289 Lymphocyte subpopulations (ext. panel) CD3,CD4,CD8,CD16(56),CD19,CD3+ HLA-DR+,CD3+CD16(56)+(EK-T),CD8+CD38+CD25+,CD3+CD56+,CD95,CD4/CD8 200 14 385
C293 Compliment Componenta C3 33 2 373
C294 Compliment Componenta C4 33 2 373
C295 Neutrophilic Bactericidal Activity (HCT test) 27 1 942
C290 Interleukin 6 34 2 445
C291 Interleukin 8 34 2 445
C296 Interleukin 10 34 2 445
C298 Tumor Necrosis Factor 34 2 445
C281 Interleukin 1 Beta 50 3 596
C307 Determination of amyloid - beta (1-40) 75 5 394
B704 Oligoclonal IgG in liquorrhea & serum 120 8 631
Diagnosis Of Auto-Immune Diseases
C167 Determination of аntibodies to nuclear antigens (ANA), IgG, 25 antigens 105 7 552
C168 Determination of АВ to liver antigens,IgG,7 antigens:M2 /nPDC, gp210, sp100, LKM1, LC1, SLA, f-actin 45 3 237
C169 Determination of аntibodies for diagnosis of polymyositis/ scleroderma, IgG, 8 antigens 67 4 819
C171 Determination of AB to extractable nuclear antigens (ENA screen) and nucleosomes, IgG, 7 antigens 21 1 510
C175 Determination of antibodies to myeloperoxidase (MPO), IgG; quantitative determination 16 1 151
C176 Determination of antibodies to proteinase 3 (PR3), IgG; highly sensitive method; quantitative determination 16 1 151
C225 Thyroglobulin antibody 33 2 373
C230 Thyroperoxidase antibody 33 2 373
C231 Auto AB TSH-receptor 53 3 812
C233 Antispermatic Antibodies 67 4 819
C235 AB Insulin IgG 40 2 877
C236 AB insular beta-cells 67 4 819
C317 Determining the concentration of the IgG4 subclass of immunoglobulins (diagnosis of autoimmune pancreatitis) 35 2 517
C500 Nuclear antibody (IF) 47 3 380
C505 Cardiolipin antibody IgG 47 3 380
C506 Cardiolipin antibody IgA 25 1 798
C533 Anti-dsDNA 53 3 812
C534 Anti-ssDNA 53 3 812
C535 Phospholipid Antibody IgG 53 3 812
C536 Phospholipid Antibody IgM 53 3 812
C830 Antibodies Prothrombin 40 2 877
C845 Antibodies Reticulin 47 3 380
C846 Antibodies Endomysium 47 3 380
C847 Antibodies Platelet 53 3 812
C848 Antibodies Basic Skin Membrane 73 5 250
C840 Antibodies Gliadin IgA 40 2 877
C849 Determination of antibodies to the basement membrane of the glomeruli of the kidneys, IgG 35 2 517
C850 Antibodies Gliadin IgG 40 2 877
C841 Anti-Transglutaminase IgG 47 3 380
C842 Anti-Transglutaminase IgA 47 3 380
C023 Cardiolipin antibodies, IgM 50 3 596
C029 Cytoplasmic antigen antibodies SS-A/Ro (anti-SS-A/Ro) 83 5 970
C035 Cytoplasmic antigen antibodies Jo-1 (anti-Jo-1) 83 5 970
C855 Anti CCP – Anti-cyclic citrullinated peptide antibodies 50 3 596
C854 ANCA –Anti-Neutrophil cytoplasmatic antibodies 50 3 596
C851 Beta2 – glycoprotein antibodies 50 3 596
C852 Annexin V antibodies 50 3 596
C853 ENA – extractive nuclear antibodies screen 61 4 387
C101 Anti-smooth muscle antibodies (ASMA) 50 3 596
C102 Anti-mitochondrial antibodies (AMA) 50 3 596
C201 Saccharomyces cerevisiae antibodies (ASCA) 45 3 237
C203 Scl-70 antibodies 50 3 596
C240 Antibodies acetylcholine receptor 160 11 508
C241 Antibodies aquaporin 4( NMO) 80 5 754
C242 Antibodies skeletal muscles 70 5 035
C243 Antibodies gangliosides, blot 90 6 473
C244 Myositis antibodies, blot 90 6 473
C245 Anti-neuronal antibodies, blot 110 7 912
C246 Antibodies NMDA receptor 150 10 788
C247 Antibodies Sm 50 3 596
C248 Antibodies gliadine deamidated peptides IgG 45 3 237
C249 Antibodies gliadine deamidated peptides IgA 45 3 237
C250 Antibodies RNP-70 45 3 237
C521 Immunophenotypic diagnostics of lymphoproliferative diseases(IPT LLP)) 288 20 714
C252 Immunophenotypic diagnostics of Acute leukemia and evaluation of the minimal residual disease (IPT AL and MOB) 292 21 002
C253 Blood test on APG 100 7 192
C254 Evaluation of cellular immunity / Immunity / imony the status of standard (расшифровка в таблице) 50 3 596
C256 Definition of CD20 in peripheral blood 54 3 884
C257 Typing of CD-34 + cells 54 3 884
C258 Myelogram 122 8 775
C259 Study of blood serum for the presence of antibodies to muscle specific tyrosine kinase receptors by enzyme immunoassay 75 5 394
C260 Antibodies to myelin oligodendrocyte glycoprotein Anti-MOG 75 5 394
C261 Determination of Tau protein in biological fluids 75 5 394
C262 Determination of glial fibrillar acid protein (GFAP) 96 6 905
Immune Hematological Analysis
A066 Complex "Myeloma-test" 220 15 823
A069 Determination of free light chains FLC in blood 55 3 956
A070 Determination of free light chains (FLC) in urine 35 2 517
ONCOLOGICAL TESTS
C405 PSA total 29 2 086
C410 PSA free 29 2 086
C420 AFP 29 2 086
C425 CEA 29 2 086
C430 CA 125 38 2 733
C435 CA 19-9 29 2 086
C440 CA 15-3 29 2 086
C442 CA 72 - 4 40 2 877
C443 Neuron-Specific Enolase (NSE) 60 4 315
C445 B2 microglobulin 33 2 373
C820 Cyfra-21-1 40 2 877
C822 Squamous Cell Carcinoma (SCC) 39 2 805
C821 UBC (Bladder Cancer Antigen) in urine 39 2 805
C823 HE4 40 2 877
C824 Chromogranin A 55 3 956
SEROLOGY
Syphilis Diagnosis
S000 Syphilis RPR 27 1 942
S001 Antibodies Treponema Pallidum IgG+IgM 27 1 942
S002 Total antibodies Treponema pallidum (quant) 30 2 158
S010 Syphilis TPHA 33 2 373
S091 Immunoblot Treponema pallidum IgG 103 7 408
S092 Immunoblot Treponema pallidum IgM 103 7 408
Isoserological Study
A050 ABo Blood group+rhesus factor 33 2 373
A055 Antierythrocytic antibodies (screening) 40 2 877
A056 Direct Cumbs test 33 2 373
A061 Detecting Kell antigen sistem 33 2 373
A064 Phenotyping Rh and Kell 35 2 517
DIAGNOSIS OF VIRAL INFECTIONS
C001 Anti-HIV 1/2 + antigen p24 47 3 380
C001-SC Anti-HIV 1/2 + antigen p24 state certificate 79 5 682
C004 Anti-HAV total 40 2 877
C006 Anti-HAV IgM 47 3 380
C008 HBsAg 27 1 942
C009 HBsAg (conf.test) 47 3 380
C010 HBeAg 47 3 380
C012 Anti-HBc total 40 2 877
C014 Anti-HBc IgM 47 3 380
C016 Anti-Hbe 47 3 380
C018 Anti-HBs quant. 47 3 380
C020 Anti-HCV total/ Anti-HCV IgG 40 2 877
C021 Anti-HCV IgM 44 3 165
C025 Anti-HCV (conf.test) 53 3 812
C007 Hepatitis D Virus HDV antibodies, total 28 2 014
C011 HDV antibodies, IgM 28 2 014
C013 HEV antibodies, IgG 28 2 014
C015 HEV antibodies, IgM 28 2 014
C026 Anti-CMV IgG 29 2 086
C028 Anti-CMV IgM 33 2 373
S200 Cytomegalovirus (CMV) IgG Avidity 53 3 812
C030 Anti-Rubella IgG 29 2 086
C032 Anti Rubella IgM 33 2 373
S210 Rubella IgG Avidity 38 2 733
C031 Anti-Parvovirus B19 IgG 40 2 877
C033 Anti-Parvovirus B19 IgM 40 2 877
C034 Anti Mumps IgG 53 3 812
C036 Anti Mumps IgM 53 3 812
C038 Anti Measles IgG 53 3 812
C040 Anti Measles IgM 53 3 812
C044 Anti-HSV 1 IgG 47 3 380
C046 Anti-HSV 1 IgM 53 3 812
C048 Anti-HSV 2 IgG 47 3 380
C050 Anti-HSV 2 IgM 53 3 812
C041 Human Herpes Virus 6 type antibodies (anti-HHV6) , IgG 47 3 380
C052 Anti-Varicella Zoster IgG 53 3 812
C054 Anti Varicella Zoster IgM 53 3 812
C058 Anti-EBV-VCA IgG 53 3 812
C060 Anti-EBV-VCA IgM 53 3 812
C450 Adenovirus infection 67 4 819
C856 Anti- encephalitis IgG 55 3 956
C857 Anti- encephalitis IgM 55 3 956
C094 IgG Respiratory syncytial virus 35 2 517
C096 IgM Respiratory syncytial virus 35 2 517
C152 IgG Dengue virus 25 1 798
C153 IgM Dengue virus 25 1 798
C154 Antibodies to Clostridium tetani (quantitative) 35 2 517
C155 Antibodies to nuclear antigen of Epstein-Barr lgG / EBV EBNA lgG 55 3 956
C156 Antibodies to early proteins of Epstein-Barr lgG / EBV EA IgG 55 3 956
DIAGNOSTICS OF BACTERIAL INFECTIONS
C062 Helicobacter pylori antibody quantitative 47 3 380
C064 Helicobacter pylori antibody blot 80 5 754
C072 Anti IgG Chlamydia trachomatis (IF/quant) 47 3 380
C080 Mycobacterium tuberculosis antibodies total 53 3 812
C081 Determination of antibodies to Bordetella pertussis IgA (quant.) 67 4 819
C082 Determination of antibodies to Bordetella pertussis IgG (quant.) 67 4 819
C083 Determination of antibodies to Bordetella pertussis IgM (quant.) 67 4 819
C099 M.Tuberculosis by the method of T-SPOT.TB. 130 9 350
C090 Borrelia burgdorf. IgG (qual) 67 4 819
C091 Borrelia burgdorf. IgM (qual) 67 4 819
C164 Serological diagnosis of borreliosis (immunochip) in blood and neurolynph 25 1 798
C165 Serological diagnosis of borreliosis (immunochip) in blood 13 935
C519 Anti IgG Legionella pneumophila (qual.) 89 6 401
C522 Anti IgM Legionella pneumophila (qual.) 89 6 401
C645 Brucella IgG 67 4 819
C647 Brucella IgM 67 4 819
D070 Chlamydia pneumoniae IgA 53 3 812
D071 Chlamydia pneumoniae IgG 53 3 812
D072 Anti IgM Chlamydia pneumoniae 53 3 812
D073 Chlamydia psittaci IgG (qual) 67 4 819
D074 Chlamydia psittaci IgM (qual) 67 4 819
D077 Chlamydia psittaci IgA (qual) 67 4 819
D078 Determination of IgM class antibodies to Mycoplasma hominis (quant.) 15 1 079
D079 Determination of IgG class antibodies to Mycoplasma hominis (quant.) 10 719
D110 Mycoplasma pneumoniae IgA (quant) 40 2 877
D115 Mycoplasma pneumoniae IgG (qual) 40 2 877
D120 Mycoplasma pneumoniae IgM (qual) 40 2 877
D124 IgG Yersinia enterocolitica and psevdotuberculosis 30 2 158
D125 IgA Yersinia enterocolitica and psevdotuberculosis 30 2 158
D322 AB Shigella flexneri (total) 60 4 315
D323 AB Shigella sonnei (total) 60 4 315
S070 Ureaplasma urealiticum IgA 67 4 819
S075 Ureaplasma urealiticum IgG 67 4 819
S231 Anti-Salmonella A,B,C1, C2, D, E 22 1 582
S232 Anti-Salmonella Typhi Vi-antigen 22 1 582
S233 Anti-Corinebacterium Diphtheriae 22 1 582
C053 Helicobacter pylori IgM 44 3 165
C063 Helicobacter pylori IgA 44 3 165
C103 Immunoblot Borrelia burgdorferi IgG 60 4 315
C104 Immunoblot Borrelia burgdorferi IgM 60 4 315
C123 Determination of IgA class antibodies to Chlamydia trachomatis (quant.) 10 719
C124 Determination of lgM class antibodies to Chlamydia trachomatis (quant.) 10 719
S006 Antigen Legionella pneumophilla in urine 30 2 158
S007 Determination of antigen Legionella pneumophilla in urine (express test) 25 1 798
S008 Determination of streptococcus pneumoniae antigen 25 1 798
HELMINTHIASIS DIAGNOSIS
D305 Determination of IgG class antibodies to Opisthorchis (qual.) 67 4 819
D306 Determination of IgG class аntibodies to Trichinella  (qual.) 67 4 819
D307 Determination of IgG class аntibodies to Toxocara (qual.) 67 4 819
D308 Determination of IgG class аntibodies to Echinococcus (qual.) 67 4 819
D311 Lamblia intestinalis IgG, IgM, IgA 47 3 380
D312 Lamblia intestinalis IgM 47 3 380
D315 Antibody to ascaris antigen IgG (qual.) 40 2 877
D324 Antibodies to Echinococcus gr. IgG (quantitatives) 67 4 819
D325 Antibodies to Opistorchis IgG (quantitatives) 67 4 819
D326 Antibodies to Toxocara IgG (quantitative) 67 4 819
D327 Antibodies to Trichinella lgG (quantitative) 67 4 819
D328 Antibodies Ascaris IgG (quantitative) 67 4 819
D329 The blood test for trichinosis (rostirolla) 17 1 223
D330 The blood test for toxocariasis (rostirolla) 17 1 223
D331 Blood test for clonorchiasis (IgG) by ELISA 21 1 510
D332 The blood test for anisakis (IgG) by ELISA 21 1 510
C049 Strongyloides stercoralis antibodies 44 3 165
C051 Taenia solium antibodies, IgG 44 3 165
C055 Fasciola hepatica antibodies, IgG 44 3 165
C057 Schistosoma mansoni antibodies, IgG 44 3 165
DIAGNOSIS OF ANIMACULAR INFECTIONS
C022 Toxoplasma gondii IgG (quant) 29 2 086
C024 Toxoplasma gondii IgM (qual) 38 2 733
C075 Entamoeba histolytica antibodies, IgG (RPGA) 44 3 165
S230 Trichomonas antibodies 30 2 158
S220 Toxoplasma IgG Avidity 46 3 308
C625 Entamoeba sp AB (total) 80 5 754
HORMONE TESTS
Thyroid gland tests
C200 Thyroid stimulating hormone 27 1 942
C205 Total T3 27 1 942
C210 Free T3 27 1 942
C215 Total T4 27 1 942
C220 Free T4 27 1 942
C222 Calcitonin 40 2 877
C223 Thyroglobulin 40 2 877
C224 Thyroid Binding Globulin (TBG) 40 2 877
Reproduction
B151 Dihydrotestosterone 53 3 812
C100 Follicle stimulating hormone 29 2 086
C105 Luteinising hormone 29 2 086
C106 Globulin, linking sex hormones (SHBG) 47 3 380
C110 Testosterone 29 2 086
C115 Prolactin 29 2 086
C117 Testosterone Free 47 3 380
C125 Estradiol 29 2 086
C126 Estriol Free 38 2 733
C130 Progesterone 29 2 086
C141 Inhibin В 93 6 689
C143 AMH (Anti-Mullerian Hormone) 93 6 689
C159 Definition of Macroprolactin (includes the definition of prolactin) 10 719
C227 Androstenedione 60 4 315
C400 Beta HCG 33 2 373
C404 Androstanediol glucuronide 50 3 596
C407 Diagnostic risk of preeclampsia:PLGF; Soluble fms-like tyrosine kinase-1(sFlt-1); (sFlt-1)/ (PLGF) 70 5 035
IVF83 Evaluation of ovarian reserve 197.6 14 212
AMH (Anti-Mullerian Hormone)
Follicle stimulating hormone
Fertility specialist consultation
C460 Determination of chorionic gonadotropin, (free Beta-subunit), ASTRAIA program 64 4 603
C461 Determination of plasma protein A (PAPP-A), ASTRAIA program 64 4 603
FUNCTIONAL STATE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
B525 Ketosteroids-17 (urine) 38 2 733
B531 17-alpha-Hydroxy-Progesteron 29 2 086
C120 Cortisol 29 2 086
C135 Dehydroepiandrosterone 33 2 373
C140 Adrenocorticotrophin 53 3 812
C160 Determination of polyunsaturated fatty acids of the Omega-3 family: docosahexaenoic (DHA), eicosapentaenoic (EPA) - in the blood (membrane, lipoprotein and free fatty acid complex) 65 4 675
C161 Calculation of the index Omega-3 - ratio of eicosapentaenoic acid (EPA), docosapentaenoic (DPA) and docosahexaenoic acid (DHA) fatty acids to total fatty acid content in the whole blood and erythrocyte membranes Score vozniknoveriya risk of cardiovascular disease and myocardial infarction 70 5 035
C162 Determination of polyunsaturated fatty acids of the Omega-6 family: linoleic (LA), gamma-linolenic (GLA), arachidonic (AA) acids - in the blood (membrane, lipoprotein and free-fatty acid complex) 65 4 675
C163 Determination of polyunsaturated (essential) fatty acids of omega-3 and omega-6 family. Calculated indices (omega-3 index) and omega-3 to omega-6 ratio. The index of the risk of complications of cardiovascular diseases. 125 8 990
C452 Determination of cortisol in saliva 25 1 798
C453 Complex testing (stress, hormones): determination of cortisol and dehydroepiandrosterone in saliva 60 4 315
C454 The definition of a set of hormones: androgens, glucocorticoids, mineralocorticoids, progestogen them precursors and metabolites (12 indicators) 104 7 480
C462 The definition of a set of hormones: androgens, glucocorticoids, mineralocorticoids, estrogens, progestogen, their precursors and metabolites (16 indicators): 17-Oh-pregnenolone, testosterone, dehydroepiandrosterone, dehydroepiandrosterone-sulfate, аndrostenedione, cortisol, cortisone, 11-deoxycortisol, 21-deoxycortisol, deoxycorticosterone, corticosterone, estradiol, estron, estriol, progesterone, 17-hydroxyprogesterone in the blood 100 7 192
DIAGNOSTICS OF CONGENITAL & HEREDITARY DISEASES
G005 Triple test (trisomia-21; with conclusion) 1 trimester 127 9 134
G007 Triple test (trisomia-21; with conclusion) 2 trimester 127 9 134
G123 Mucoviscidosis CFTR 300 21 577
G423 A study of the fragmentation of sperm DNA by the method of SCD 250 17 981
G424 Study of DNA fragmentation in sperm by TUNEL (without gradient) 250 17 981
METABOLISM OF BONE TISSUE
C131 Osteocalcin 46 3 308
C132 Parathormone 47 3 380
C144 Beta – CrossLaps (product of degradation of I type collagen) 44 3 165
C147 Bone resorption - deoxypiridinolin 67 4 819
METABOLIC NATRIUM & WATER CONTROL OF HORMONE SYSTEMS
B521 Renin, Aldosterone 80 5 754
SOMATOTROPH FUNCTIONS OF THE PITUITARY GLAND
B526 Human growth hormone 46 3 308
B527 Somatomedin-C 46 3 308
INCRETORY FUNCTION OF PANCREATIC
B532 Insulin 40 2 877
B533 Proinsulin 60 4 315
B534 С-peptide 47 3 380
B539 Antibody-GAD 53 3 812
C108 Leptin 53 3 812
C146 Gastro panel (pepsinogen I, pepsines Helicobacter pyloriogen II, gastrin 17 (basal), IgG antibodi) 75 5 394
C158 Melatonin 48 3 452
INCRETORY FUNCTION OF THE GASTROINTESTINAL TRACT
B535 Gastrin 53 3 812
BIOGENIC AMINES
C700 Serotonin 60 4 315
C800 Histamine 60 4 315
C900 Tryptase 75 5 394
FUNCTIONAL STATW OF SYMPATHIC-ADRENAL SYSTEM
C157 Catecholamines and serotonin 36 2 589
ALLERGOLOGY
Specific Ige
C310 Allergy tests/each test 20 1 438
C311 Specific IgE for Allergen Mix / qual 33 2 373
C312 Single recombinant allergic components, inhalation (One name) 20 1 438
C313 Single recombinant allergic components, nutritional (group 1) (One name) 11 791
C314 Single recombinant allergic components, nutritional 2 (group 2) (One name) 20 1 438
C315 General Inhalation Allergy Panel 160 11 508
C340 General Food Panel 160 11 508
C350 Allergy Panel/ primary screening 120 8 631
C351 Allergy pediatric panel, IgE (20 allergens) 156 11 220
C358 Children's Panel - Screening (Phadiatop Infant ImmunoCAP): Determination of specific IgE to the common allergens responsible for the development of allergies in children (without decoding). Recommended for children up to 3 years. 28 2 014
C359 Inhalation panel - Screening (Phadiatop ImmunoCAP): determination of specific IgE to inhalant allergens (without decoding) 22 1 582
С362 Antibacterial drugs (antibiotics) (specific IgE), one name. 9 647
С363 Analgesics and non-steroidal anti-inflammatory drugs (specific IgE). One name. 9 647
С364 Local anesthetics (specific IgE). One name. 9 647
C365 Antibacterial drugs (antibiotics) (specific IgG). One name. 17 1 223
C366 Analgesics and non-steroidal anti-inflammatory drugs (specific IgG). One name. 17 1 223
C367 Local anesthetics (specific IgG). One name. 17 1 223
C368 Phadiatop Infant ImmunoCAP - Children's screening panel. Determination of specific IgE for the most common allergens responsible for the development of allergies in young children (without decoding) / Recommended for children under 5 years. (Number of determinations) 27 1 942
C369 Phadiatop ImmunoCAP - Inhalation screening panel: determination of specific IgE to the main inhalation allergens (without decoding) (quantitative determination) 22 1 582
C370 Allergochip ImmunoCAP ISAC (112 allergic components ) 425 30 567
C381 The individual allergens, the technology ImmunoCAP, Phadia AB (one name) 12 863
SPECIFIC IgG
C341 Determination of IgG class antibodies to 90 food allergens (food intolerance) 320 23 015
C463 Determination of class-specific immunoglobulin (IgG) for evaluation of nutritional maladjustment within the program "Immunohealth IT" 260 18 700
PCR
P018 DNA Salmonella, Shigella, Campylobacter, Adenovirus, DNA E.coli(EIEC), RNA Rotavirus, Astrovirus, Norovirus G2 in stool 35 2 517
P019 DNA Salmonella species in stool 25 1 798
P021 Colibacillosis 40 2 877
DIAGNOSIS OF VIRAL INFECTIONS (PCR)
P003 Human Papilloma virus 16,18,31,33,35,39,45,51,52,56,58,59 39 2 805
P009 Mycoplasma pneumoniae DNA 22 1 582
P029 RNA of influenza virus А, А/Н1N1/CA/2009, B 67 4 819
P030 HSV I & II 20 1 438
P031 Human Papilloma virus 31, 33 20 1 438
P032 Human Papilloma virus 6,11 20 1 438
P033 Herpes Simplex virus II 20 1 438
P035 H. Papilloma virus 16, 18 20 1 438
P042 Varicella-Zoster virus 20 1 438
P070 Cytomegalovirus 20 1 438
P080 Epstein-Barr virus 20 1 438
P105 Human Papilloma virus sp. 20 1 438
P004 Rubella Virus in blood (qual) 40 2 877
P120 Herpes Simplex virus VI (qual) 18 1 295
P125 Enterovirus (RNA) 33 2 373
P126 DNA Pneumocystis carinni 17 1 223
P127 ARVI diagnostic: RNA of respiratory syncytial virus, RNA of metapneumovirus, RNA of parainfluenza virus 1,2,3,4 types, RNA of coronaviruses, RNA of rhinoviruses, DNA of adenoviruses B,C,E groups, DNA of bocaviruses 50 3 596
P128 Laboratory examination of tick to identify RNA/DNA pathogens transmitted by ticks: tick-borne encephalitis, borreliosis (Lyme disease), anaplasmosis, ehrlichiosis 70 5 035
P129 RNA Zika virus (blood) 80 5 754
P130 RNA Zika virus (ejaculate) 33 2 373
P131 RNA Zika virus (Amniotic fluid) 33 2 373
P133 Agroforestry-34 A screening study of the microflora of the urogenital tract of men (quantitative) 70 5 035
P134 Familar-24 Screening study of the microflora of the urogenital tract in women (quantitative) 30 2 158
P135 Neisseria meningitidis; Haemophilus influenzae; Streptococcus pneumonia: detection of DNA 15 1 079
P136 Determination of HCV RNA/ HBV DNA/ RNA HIV type 1 and 2 (ultra-sensitive study) 52 3 740
DIAGNOSIS OF BACTERIAL INFECTIONS (PCR)
P001 Chlamydia pneumoniae 20 1 438
P036 M.Tuberculosis-M.bovis 22 1 582
P038 Streptococcus group A (pyogenes) 22 1 582
P065 Listeria monocytogenes 22 1 582
P075 Pseudomonas aeruginosa 22 1 582
P085 Bordetella pertussis (PCR) 22 1 582
P095 Helicobacter pylori 38 2 733
P097 Haemophilus influenzae 20 1 438
P098 Streptococcus pneumoniae 20 1 438
P099 DNA Treponema pallidum 20 1 438
P103 Legionella pneumophila 10 719
P138 Study of feces on Yersinia pseudotuberculosis by PCR 10 719
DIAGNOSIS OF UROGENITAL INFECTIONS (PCR)
P000 Chlamydia trachomatis 20 1 438
P005 Mycoplasma hominis 20 1 438
P006 Mycoplasma genitalium 20 1 438
P015 Ureaplasma species 20 1 438
P016 Ureaplasma urealiticum (T-960) & Ureaplasma parvum (Parvo) 20 1 438
P020 Neisseria gonorrhoeae 20 1 438
P025 Gardnerella vaginalis 20 1 438
DIAGNOSIS OF PROTOZOA INFECTIONS (PCR)
P010 Trichomonas vaginalis 20 1 438
P012 Toxoplasma gondii 22 1 582
DIAGNOSIS OF FUNGAL INFECTIONS (PCR)
P037 Candida albicans (PCR) 22 1 582
DIAGNOSIS OF HEPATITIS (PCR)
P040 Hepatitis B quant. (HBV-DNA) 53 3 812
P045 Hepatitis B qualitive (HBV-DNA) 33 2 373
P050 Hepatitis C quant. (HCV-RNA) 253 18 197
P055 Hepatitis C qualitive (HCV-RNA) 38 2 733
P060 HCV-RNA (genotype determination) 40 2 877
P061 Hepatite G qual. (HGV-RNA) 40 2 877
P062 Hepatite D qual. (HDV-RNA) 40 2 877
P008 Hepatitis A Virus RNA (HAV-RNA) 40 2 877
P007 Determination of DNA of hepatitis TT virus (qual.) (TTV-DNA) 33 2 373
P063 Genotype of hepatitis B 35 2 517
P101 Hepatitis C Virus RNA (ultrasensitive method) 75 5 394
P056 RNA/DNA of HIV type 1, ultrasensitive test (qualitative research) 186 13 378
P132 Definition of HIV RNA (type 1) (quantitative) 76 5 466
P137 Blood test for Dirofilariasis by PCR 25 1 798
GENETIC ANALYSIS
G119 Complex genetic analysis of blood on the susceptibility to alcohol and drugs: analysis of polymorphisms in genes OPRM1 (DRD2), ANKK1, ALDH2, ADH2, DAT1 150 10 788
G122 SNP identification in human IL28B gene 60 4 315
G134 Hereditary Neuropathy with Liability to Pressure Palsy. Mutations of PMP22 gene 230 16 542
G135 Hereditary Neuropathy with Liability to Pressure Palsy. Copy number variation PMP22 gene 210 15 104
G136 FISH panel Myelodysplastic syndrome (6 probes) 220 15 823
G137 CYP2D6 analysis polymorphisms 140 10 069
G138 Determination of hereditary nonpolyposis colon cancer (Lynch syndrome) 430 30 927
G139 Familial adenomatous polyposis , polypoid colon cancer 430 30 927
G154 Chromosomal Microarray Analysis (CMA) prenatal (standard) 574 41 284
G155 Chromosomal Microarray Analysis (CMA) prenatal (complicated) 820 58 977
G156 BRCA1 и BRCA2 polymorphism 225 16 183
G159 Sequence SCN1 A (Dravet syndrome) 825 59 337
G160 Fragile X mental retardation syndrome (methylation) 188 13 522
G161 Fragile X mental retardation syndrome, premutation (PCR) 263 18 916
G162 Clinical sequencing ekzom, the family (4000 genes) 1700 122 269
G163 Locus analysis of microdeletions AZF Y-chromosome (1person) 135 9 710
G164 Analysis of polymorphisms associated with the metabolism of lactose (2 points) 40 2 877
G170 HLA II class typing (DRB1, DQA1, DQB1) 150 10 788
G185 PGD of family translocations (QF-PCR) preparatory stage: development of individual test systems (markers (probes), analysis informative for family) 760 54 662
G191 PGD ​​of monogenic diseases (QF-PCR) (confirmed diagnosis and genotype) preparatory stage: development of individual test systems (markers, analysis informative for family, study of disease mutations) 760 54 662
G192 PGD ​​of monogenic diseases (QF-PCR) (confirmed diagnosis genotype not known) preparatory stage: development of individual test systems (markers, analysis informative for family, study of disease mutations) договорная
G197 Calreticulin (CALR) 77 5 538
G198 Ehlers-Danlo syndrome type IV. Search for frequent mutations in the PLOD1 gene 130 9 350
G199 Leukodystrophy and Leukoencephalopathy next-generation sequencing panel for 59 genes 538 38 695
G216 Genetic predisposition to breast cancer and ovarian cancer 120 8 631
G218 Genetic predisposition to breast cancer in long-term hormonal contraception 230 16 542
G232 Stomach cancer 396 28 482
G233 Pancreas cancer 84 6 042
G234 Determination of genetic polymorphisms associated with the risk of developing breast and ovarian cancer (full-scaled) 560 40 277
G235 Determination of genetic polymorphisms associated with the risk of developing breast and ovarian cancer (shorten) 200 14 385
G254 Sensorineural hearing loss 36 2 589
G255 Muscle atrophy 60 4 315
G256 Long QT syndrome 84 6 042
G264 Lactose intolerance 67 4 819
G265 Gilbert's syndrome - a confirmatory test 40 2 877
G268 Psoriasis 60 4 315
G272 Determination of sensitivity to the Fluorouracil and Capecitabine (Xeloda) 40 2 877
G280 Activity of the VEGF gene in cancer of the thyroid gland (blood tests) 40 2 877
G280 Activity of the VEGF gene in cancer of the thyroid gland (blood tests) 166 11 939
G281 Activity of the VEGF gene in cancer of the thyroid gland (blood tests) 166 11 939
G282 Activity of genes VEGF, VEGF in cancer of the thyroid gland (blood tests) 191 13 737
G289 Activity GATA2 gene for prostate cancer (blood test) 166 11 939
G290 Activity IGF1 gene for prostate cancer (blood test) 166 11 939
G291 Activity IGF2 gene for prostate cancer (blood test) 166 11 939
G292 Activity IL4 gene for prostate cancer (blood test) 166 11 939
G293 Activity IL10 gene for prostate cancer (blood test) 166 11 939
G294 Active genes GATA2, IGF1, IGF2, IL4, IL10 in prostate cancer (blood test) 264 18 988
G295 Germinal mutation of the choice of any international database (with the obligatory indication of gene polymorphism and localization) 111 7 983
G300 Preimplantation aCGH diagnosis of chromosomal abnormalities (fresh cycle) for each specimen 548 39 414
G303 Preimplantation CGH diagnosis of chromosomal abnormalities cryo cycle (translocation) for each specimen 913 65 666
G304 Preimplantation NGS diagnosis of chromosomal abnormalities (cryo cycle) for each specimen 488 35 099
G305 PGD ​​monogenic diseases 1 cat of complexity: development of individual test systems (Rh, cystic fibrosis , spinal amyotrophy, fam Mediterranean fever, Duchenne muscular dystrophy, Becker and other dis, which is partially developed test system, dev of HLA- typing) 1420 102 131
G306 PGD ​​monogenic diseases 2 category of complexity: development of individual test systems (diseases for which there are no ready-made elements of the test system) 2435 175 133
G307 PGD ​​monogenic diseases 3 category of complexity: development of individual test systems (PGD for simultaneous diagnosis of two diseases, or more genes of disease) 4058 291 864
G308 PGD ​​monogenic diseases 1 category of complexity 1217 87 531
G309 PGD ​​monogenic diseases 2 category of complexity 2029 145 932
G310 PGD ​​monogenic diseases 2 category of complexity 3043 218 862
G315 Full sequencing of exome 2046 147 155
G316 Panel "Diseases of conjunctive tissue" 640 46 031
G317 Panel "Patrimony of cardiopathy" 614 44 161
G318 Arrhythmogenic dysplasia / cardiomyopathy of the right stomach: search for mutations in the gene SCN5A 625 44 952
G319 Search for mutations in the gene CAV 3 129 9 278
G320 Syndrome of lengthened interval QT (Sequencing of genes KCNQ 1, KCNE 1,KCNQ 2, KCNH2, KCNJ2, SCN5A, SCN4B, CAV3) extended, 8 of genes 605 43 514
G321 Panel "Hypertension" 80 5 754
G322 Panel "Hypertension and selection of pharmaceutical drugs" 140 10 069
G323 Velocardiofacial syndrome: searching for mutations in TBX1 gene 345 24 814
G324 Velocardiofacial syndrome: searching for deletions in region 22q11 172 12 371
G325 PGS: QF-PCR assay of 1 embryo for 24 chromosomes including X and Y 550 39 558
G326 PGS: QF-PCR assay of additional embryo for 24 chromosomes including X and Y 235 16 902
G327 PGD: QF-PCR assay of inherited translocations, 1 embryo 155 11 148
G328 PGD: QF-PCR assay of monogenic family disease, 1 embryo 155 11 148
G329 Complex test PGD+PGS (QF-PCR assay). Preliminary stage: development of an individual test system for PGD monogenic family disease 742 53 367
G330 Complex test PGD+PGS (QF-PCR assay). PGD monogenic family disease / translocation) + (PGS 24 chromosomes) 1 embryo 536 38 551
G331 Complex test PGD+PGS (QF-PCR assay). PGD monogenic family disease / translocation) + (PGS 24 chromosomes), additional embryo 227 16 327
G332 Partial analysis of the ABCD1 gene (X-linked adrenoleukodystrophy, MIM 300100) 230 16 542
G344 The definition of ADZIC in plasma (diagnosis peroxisome diseases) 75 5 394
G345 Molecular genetic testing for SPAST-gene mutation associated with Hereditary spastic paraplegia (HSP) 505 36 321
G346 Molecular genetic testing for ATL1-gene mutation associated with Hereditary spastic paraplegia (HSP) 464 33 372
G347 Molecular genetic testing for BSCL2-gene mutation associated with Hereditary spastic paraplegia (HSP) 217 15 607
G348 Genetic testing for gross SPAST- and ATL1-gene deletion and duplication associated with Hereditary spastic paraplegia (HSP) 150 10 788
G349 Molecular genetic testing for GJC2-gene mutation associated with Hereditary spastic paraplegia (HSP) 138 9 925
G350 Molecular genetic testing for CYP2U1-gene mutation associated with Hereditary spastic paraplegia (HSP) 159 11 436
G351 Molecular genetic testing for L1CAM-gene mutation associated with Hereditary spastic paraplegia (HSP) 556 39 989
G352 Study of gene mutation revealed among family members with Hereditary spastic paraplegia (HSP) 58 4 172
G353 Prenatal DNA-diagnostics for Hereditary spastic paraplegia (HSP) 167 12 011
G376 Molecular karyotyping abortion material OPTIMA 285 20 498
G377 Chromosomal micrometrical analysis of abortive material Standard 530 38 119
G379 PGS 24 chromosomes by a method of NGS (for patients with normal blood karyotype) 420 30 208
G380 PGD for structural chromosome rearrangements NGS (for patients with balanced chromosomal rearrang.) 400 28 769
G388 The allocation and storage of DNA 20 1 438
G389 Panel "Disorders of hemostasis" 30 tokens 210 15 104
G394 Cytogenetics: FISH (fluorescent crossbreeding in situ) (for one token) 147 10 573
G395 Cytogenetics: FISH (fluorescent crossbreeding in situ) with whole chromosome breakdown, 1 chromosome 133 9 566
G396 Cytogenetics: MDS FISH (fluorescent crossbreeding in situ) panel with (6 probes) 244 17 549
G397 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel of MDS according to IPSS (9 probes) 355 25 533
G398 Cytogenetics: FISH (fluorescent crossbreeding in situ) bar in AML (9 probes) 355 25 533
G399 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel when ALL the (7 probes) 277 19 923
G400 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel with multiple myeloma (10 probes) 366 26 324
G401 Cytogenetics: FISH (fluorescent crossbreeding in situ) bar in CLL (8 probes) 310 22 296
G402 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel (hypereosinophilic syndrome, chronic eosinophilic leukemia, chronic myeloproliferative neoplasms) 2 probes 222 15 967
CHROMOSOMAL ANALYSIS
G050 Karyotype (cytogenetic analysis) 200 14 385
TISSUE TYPING
G020 HLA TYPING B27 200 14 385
MICROBIOLOGY
M000 Bacteriology & Antibiogram 80 5 754
M003 Bacterioscopic stained smear 30 2 158
M005 Microbiological study of discharge from the urethra to urealyticum ureaplasma, mycoplasma of hominis, with resistogramm 47 3 380
M010 Mycology & Fungigram 90 6 473
M100 Disbacteriosis 107 7 696
M130 Corynebacterium diphtheriae (BL) 29 2 086
M135 Enteropathogenic bacteria (BD) 35 2 517
M170 Staphylococcus aureus 52 3 740
M350 Yersinia enterocolitica (stool culture) 52 3 740
M560 Listeria (with resistance) 38 2 733
M239 Inoculation on the aerobic and facultative aerobic bacteria (MRGN-strain) with definition of sensitivity to antibiotics (nose, pharynx, sinuses) 15 1 079
M240 Inoculation on Staphylococcus aureus (MRSA-strain) with the definition of sensitivity to antibiotics (nose, pharynx, sinuses) 20 1 438
M241 Inoculation on the aerobic and facultative aerobic bacteria (MRGN-strain) with definition of sensitivity to antibiotics (tela, stab sequestrate) 15 1 079
M242 Inoculation on Staphylococcus aureus (MRSA-strain) with the definition of sensitivity to antibiotics (tela, stab sequestrate) 15 1 079
M237 The detection Candida anti-mannan antibodies in serum Platelia, Candida Ab Plus 52 3 740
M238 Determination of fungi metabolites (determination of Candida mannan antigen in blood serum, Platelia Candida Ag) 52 3 740
M243 Inoculation of N. meningitidis with the definition of sensitivity to antibiotics 11 791
MICOLOGY
M160 Microbiology of lavage fluid, nasopharyngeal swabs, wash water sinuses, ear discharge by fungi (microscopy and culture, 1 localization) 150 10 788
M055 Mycology of hair by dermatophytes (Dermatophyton) microscopy and culture 100 7 192
M151 Microbiology of blood by fungi (double reseeding) 130 9 350
M090 Micology Aspergillus spp. of sputum (microscopy and culture) 80 5 754
M095 Micology Cryptococcus neoformans of sputum (microscopy and culture) 130 9 350
M156 Mycology of sputum by fungi, microscopy and culture 80 5 754
M175 Microbiology of sputum by anaerobic and facultative anaerobic microbes (actinomycetes) 130 9 350
M080 Mycology Aspergillus spp. of nasopharyngeal swabs (culture) 110 7 912
M171 Microbiology of abscess by anaerobic and facultative anaerobic microbes (actinomycetes) 120 8 631
M131 Aspergillus niger. of ear discharge (micology), Aspergillus spp. culture and filamentous fungi 80 5 754
M136 Mycology of conjunctiva discharge by fungi (culture) 100 7 192
M165 Bacteriology of traumatic discharge by anaerobic and facultative anaerobic microbes (actinomycetes) 120 8 631
M060 Mycology of skin and nail samples by dermatophytes (Dermatophyton) culture, 1 localization 70 5 035
M116 Mycology Cryptococcus neoformans of cerebrospinal fluid (microscopy and culture) 80 5 754
M195 Metabolite of fungi (Cryptococcus antigen in "Cryptococcus", BIO-RAD, mannan) 90 6 473
M235 Metabolite of fungi (Aspergillus antigen in Aspergillus EIA, BIO-RAD, galactomannan) 115 8 271
M236 Aspergillus spp. Antibodies (Aspergillus fumigatus Igg) 80 5 754
COMPLEX LABORATORY TESTS
K011 Fibro Test/ Acti Test 300 21 577
Bilirubin total
APO-A-1-protein
Gamma Glutamyle Transferase
Alanine Amino Transferase
Aspartate Amino Transferase
Alpha-2-Macroglobuline
Haptoglobin
Results processing
K012 FibroMax Test 380 27 331
Bilirubin total
APO-A-1-protein
Gamma Glutamyle Transferase
Alanine Amino Transferase
Aspartate Amino Transferase
Alpha-2-Macroglobuline
Haptoglobin
Glucose
Triglycerides
Cholesterol
Results processing
QUANTITATIVE ANALYSIS OF CYTOKINE MRNA EXPRESSION USING RT-PCR
G006 MMP-2 - study of lung cancer invasiveness 89 6 401
G100 TIMP-2 - study of lung cancer invasiveness 89 6 401
G008 TGF B - study of prostate cancer invasiveness 89 6 401
PREDILECTION OF BREAST / OVARY CANCER
G009 BRCA1 5382insC 50 3 596
G010 BRCA1 4153delA 50 3 596
G011 BRCA1 185delAG 50 3 596
G012 BRCA1 C61>G 50 3 596
G014 BRCA1 2080delAA 50 3 596
G015 BRCA2 6174delT 50 3 596
G016 BRCA2 9318 delAAAA 50 3 596
G021 CHEK2 ivs2+1G>A 50 3 596
QUALITY EXPRESSION OF CHYMERA ONCOGENES BY RT-PCR
G052 BCR-ABL p210 t(9;22) 85 6 113
G053 BCR-ABL p190 t(9;22) 85 6 113
G054 BCR-ABL p230 t(9;22) 85 6 113
MUTATIONS, CHIMERISM
G097 Mutation in D816V gene c-KIT, typical of mastocytosis 94 6 761
G098 Mutation profile: V617F Jak-2, delection 12 exon Jak-2, Mpl-1 W515L/K. С 150 10 788
G099 Mutation V617F in 14 exon gene Jak-2 kinase – quantity 89 6 401
G104 Hemochromatosis, mutation in a gene HFE-C282Y and H63D (PCR- detection) 60 4 315
G106 Mutation V617F in 14exon gene Jak-2 kinase -quality 56 4 028
G107 Deletion in 12 exon gene Jak-2 kinase 80 5 754
G114 Determination of thrombophilia markers (FII, FV, MTHFR) 105 7 552
G152 Germinal mutation 60 4 315
G371 Search 12 the most frequent mutations in the gene ATP7B (Wilson Disease-Konovalova) 105 7 552
G372 Search of mutations in the gene ATP7B (Wilson Disease-Konovalova) 680 48 908
G373 Search identified in this family of mutations have a relative (Wilson Disease-Konovalova) 83 5 970
G374 Prenatal DNA diagnosis (Wilson's Disease) 167 12 011
G381 PMP22(1.5-MB Del) 24 1 726
G382 PMP22 (2-BP DEL.,207TC; rs587776691) 24 1 726
G383 PMP22 (1-BP INS, 325G; rs80338763) 24 1 726
G384 PMP22 (Ala67Thr: rs104894623) 24 1 726
G385 PMP22 (EX2-3DEL; nsv1197510) 24 1 726
G386 PDGFRα, FIP1L1 - markers of eosinophilia 85 6 113
G387 Genotyping on the RH factor, including heterozygous carrier 126 9 062
G390 Panel "Phacomatosis and hereditary cancer" 630 45 312
G407 Determination of mutations in the WT1 gene by direct sequencing (7-10 exons) 127 9 134
G408 Analysis of carriers of spinal ametropia 144 10 357
G409 Screening for hereditary diseases (2500 genes) 632 45 455
G410 Screening for hereditary diseases (5 diseases, 15 mutations) 60 4 315
G411 Search for frequent mutations in genes CFTR, PAH, SMN1, GJB2 209 15 032
G412 Search 9 most frequent mutations in the CYP210HB gene 144 10 357
G413 Analysis of spinal amyotrophy carrier for married couple (2 pers.) 171 12 299
G414 Determination carrier known inherited mutations in the family (CDH1 genes, MLH1 / MSH2, BRCA2) 78 5 610
G415 Solo ABC: Analysis of gene data BRCA1.BRCA2.CHEK2.ATM with the report in the electronic form 1108 79 691
G416 Solo ABC: Analysis of gene data BRCA1.BRCA2.CHEK2.ATM with report in electronic form and on paper 1218 87 602
G417 Solo Risk:hereditary mutations associated with the risk of hereditary oncol dis. in an electr. form 1528 109 899
G418 Solo Risk:hereditary mut assoc with the risk of hereditary oncol dis in an electr form,a paper car 1639 117 882
G420 Confirmation of previously found mutation sequencing by Sanger 107 7 696
G429 Parkinson disease - mutation screening of exons 8 to 11 of the GBA gene 107 7 696
G430 Wilson-Konovalov disease - screening of the coding region of the atp7b gene 637 45 815
G431 BAS and frontotemporal dementia - expansion in c9orf72 gene 85 6 113
G432 Neurodegenerative diseases - APOE gene genotyping 54 3 884
G433 Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoecephalopathy (CADASIL): analysis of the most frequent mutations in the NOTCH3 gene 107 7 696
G434 Frontal-temporal dementia - mutational screening of the coding region of the GRN gene 255 18 340
G435 BAS - screening of the coding region of the SOD1 gene 255 18 340
G442 The blood test for the syndrome Gerstmann-Straussler-Sheinker: search for mutations in the gene PRNP 160 11 508
G443 Complex genetic research: hereditary diseases of the gastrointestinal tract 635 45 671
URG Extra charge for urgency (with a minimum of 50) увел. тарифа на 50%/ extra charge 50%
HISTOLOGICAL LABORATORY
SURGICAL SAMPLES
M200 Histology of surgical samples, 1 sample 213 15 320
H250 Histology of tumor surgical samples 389 27 978
H299 Intraoperative (urgent) histology and cytology 200 14 385
H270 Histology of breast wide local excision (lumpectomy) specimen 389 27 978
H271 Histology of mastectomy speciment 367 26 396
H272 Histology of sentinel lymph node with IHC if necessary 280 20 138
H273 Histology of lymph node dissection speciment 213 15 320
DIAGNOSTIC (BIOPSY) MATERIAL
M201 Histology simple 1-2 samples 127 9 134
M202 Hystology with supplementary staining for helicobacter pylori 227 16 327
M203 Multiple histology 3 samples and more 344 24 742
H204 Histology of the prostate punctates 358 25 749
H205 Histology of scrapings of the uterus 213 15 320
H206 Histology of the mammary gland punctates 213 15 320
H207 Histology of liver bioptates 213 15 320
H208 Histology of CT-guideline needle biopsy 397 28 554
H209 Histology of skin (PUNCH-biopsy) 213 15 320
H210 Histology of skin tumors 198 14 241
H211 Histology of bone marrow patho bioptate 280 20 138
CONSULTATIONS OF SPECIMENS
H230 Consultation of histology and cytology slides 156 11 220
H231 Consultation with the making of histology specimens with paraffin blocks 224 16 111
H232 Consultation with the making of specimens and immunohistochemistry 358 25 749
H233 Consultation of histology specimens of specialist - pathologist from U.S., Europe, Israel (telepathology) 389 27 978
H234 Consultation histological slides by a qualified pathologist USA, University of Southern California 445 32 006
H240 Scanning histological (cytology) specimens to make digital copies (1slide) 92 6 617
CYTOLOGY
M300 Citology / 1 lame 75 5 394
M301 Cytologic cervical smear (Pap Smear) 94 6 761
M302 Integrated cytology PAP-test and HPV typing 115 8 271
M303 Complex immunocytochemical study of thyroid neoplasms 450 32 365
Z302 Cytology of aspirates from the uterus, the prints with an intrauterine device 78 5 610
Z303 Cytology of the mammary gland 75 5 394
Z304 Cytology of the thyroid gland punctate 117 8 415
Z305 Cytology of liquid 78 5 610
Z306 Cytology of endoscopic material 56 4 028
Z307 Cytology of scrapings from the surface of the skin and mucous 78 5 610
Z308 Cytology of surgical samples 78 5 610
Z309 Cytology of the lymph nodes punctate 94 6 761
Z311 Urine cytology for diagnosis cancer of the urinary tract 78 5 610
Z314 Identification of human papilloma DNA virus with PCR method (HPV full testing, fluid) 20 1 438
IMMUNOHISTOCHEMISTRY
I001 Immunohistochemistry of breast cancer (receptors PR, ER and Her2/neu + Ki-67) 278 19 995
I002 Immunohistochemical differential diagnosis of tumors 389 27 978
I003 Immunohistochemistry of one marker panel differential diagnosis 213 15 320
I004 Immunohistochemical diagnosis of lymphoproliferative disease (lymphoma) 457 32 869
I005 Immunohistochemical (IHC) testing for Mismatch Repair Proteins in carcinomas to exclude Lynch syndrome 256 18 412
I006 Immunocytochemistry 256 18 412
I007 Immunohistochemistry with assessment of the mutational status of the ALK gene 220 15 823
I008 Complex histological and immunohistochemical analysis of biopsies of the bladder 256 18 412
GENETIC ANALYSIS
G117 Cytogenetic study of the bone marrow (standard) 156 11 220
I500 Her2/neu gene mutation detection by FISH/CISH in sections from paraffin blocks 400 28 769
I501 Cytogenetic study by hybridization in situ FISH/CISH (one tube) in sections from paraffin blocks 305 21 937
I506 Identification of the codeletion 1p/19q by in situ-hybridization in a sample of tumor tissue 308 22 152
I507 Determination of the mutational status of the ROS1 gene by in situ hybridization in a tumor tissue sample 313 22 512
I508 Determination of the mutational status of the RET gene by in situ hybridization in a tumor tissue sample 313 22 512
I509 Determination of the mutational status of the MET gene by in situ hybridization in a tumor tissue sample 313 22 512
I510 Cytogenetic study (analysis of stable chromosomal aberrations) by in-situ hybridization in a tumor tissue sample 301 21 649
I511 Determination of the mutational status of the NMYC gene by in situ hybridization in a tumor tissue sample 315 22 656
I512 Determination of the mutational status of the CMYC gene by in situ hybridization in a tumor tissue sample 315 22 656
Identification of activating mutations that determine sensitivity to targeted therapy
G200 KRAS mutation exon 2 (codon12 13) (sensitivity to cetuximab) 287 20 642
G201 EGFR mutation exons 18,19,21 (sensitivity to gefitinib/erlotinib) 287 20 642
G202 EGFR gene amplification (sensitivity to cetuximab) 259 18 628
G203 BRAF mutation exon 15 (V600E) (sensitivity to vemurafenib for melanoma and sensitivity to cetuximab for colorectal cancer 178 12 802
G204 c-KIT mutation exons 9,11,13,17 (sensitivity to imatinib for GIST and melanoma) 236 16 974
G205 PDFRRa mutation exons 12,18 (sensitivity to imatinib for GIST) 112 8 055
G206 ALK gene displacement (sensitivity to crizotinib and pemetrexed) 328 23 591
G207 Determination of the methylation status of the promoter body and MGMT gene 177 12 730
G368 Tissue test in ovarian cancer treatment 3213 231 089
G369 Agression degree in prostate cancer 3570 256 766
G370 Prognostic test for evaluation of distant metastasis growth and disease progression in breast cancer (IVD) 3543 254 824
G403 Complex analysis of data on biomarkers obtained by Next Generation Seq 2436 175 205
G404 Express research of additional biomarkers 226 16 255
G405 Biological profiling of tumor (Caris Target Now) only NGS 3500 251 731
G406 Biological profiling of tumor (Caris Target Now) full profile 6000 431 539
G419 Study of genes mutations of BRCA1/BRCA2, CHEK2, ATM in tumor tissue by PCR method 1108 79 691
G426 Molecular genetic testing of mutations in IDH1 gene in a sample of tumor tissue 162 11 652
G427 Molecular genetic testing of mutations in IDH2 gene in a sample of tumor tissue 162 11 652
G436 Molecular genetic study of mutations in the PIK3CA gene in a tumor tissue sample 145 10 429
G437 Molecular genetic research in the NRAS gene in biopsy/surgical tissue sample 145 10 429
G438 Immunohistochemical study of PDL-1 gene expression 165 11 867
G439 Solo genetics standard: tumour tissue analysis (17 biomarkers) by the NGS method 737 53 007
G440 Solo Genetics Advanced: tumour tissue analysis (50 biomarkers) by NGS method 1495 107 525
G441 Comprehensive genetic study of thyroid tumors by NGS 1357 97 600
Diagnosis of soft tissue sarcoma and Ewing sarcoma
I502 Translocation in Ewing sarcoma with displacement of EWS gene 305 21 937
I503 Translocation in alveolar rhabdomyosarcoma PAX3/FKHR 249 17 909
I504 Translocation in synovial sarcoma SYT/SSX 305 21 937
I505 Translocations in myxoid liposarcoma with displacement of FUS gene 305 21 937

    Mobile application EMC